Contraception and Pregnancy Planning in Women With Congenital Heart Disease
Opinion statement The cardiovascular risk of pregnancy among women with congenital heart disease is heterogeneous, ranging from negligible to prohibitively high. Nonetheless, many of these patients do not report being counseled about the potential risks, and the incidence of unintended pregnancy is...
Gespeichert in:
| Veröffentlicht in: | Current treatment options in cardiovascular medicine 2015-11, Vol.17 (11), p.50, Article 50 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 11 |
| container_start_page | 50 |
| container_title | Current treatment options in cardiovascular medicine |
| container_volume | 17 |
| creator | Lindley, Kathryn J. Conner, Shayna N. Cahill, Alison G. Madden, Tessa |
| description | Opinion statement
The cardiovascular risk of pregnancy among women with congenital heart disease is heterogeneous, ranging from negligible to prohibitively high. Nonetheless, many of these patients do not report being counseled about the potential risks, and the incidence of unintended pregnancy is high. These women should be counseled on safe and effective contraceptive options. Long-acting reversible contraceptives, including the intrauterine devices and etonogestrel implant, are highly effective and safe for all cardiac patients. These are good options for pregnancy planning for women at elevated risk of cardiovascular complications during pregnancy, who are taking potentially teratogenic medications, or who have contraindications to estrogen-containing methods. Pregnancy management begins with pre-conceptual risk stratification and counseling regarding individual cardiovascular and fetal risks. As significant lapse in care is common at the time of transition to adult congenital cardiology care, these discussions ideally begin in pediatric clinics and continue upon transfer of care to adult congenital cardiology clinics. |
| doi_str_mv | 10.1007/s11936-015-0413-y |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2919484724</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2919484724</sourcerecordid><originalsourceid>FETCH-LOGICAL-c287y-dadbc5c49465a3343549dd9743508796133edf5bb08892a33f61babe3d5ce9743</originalsourceid><addsrcrecordid>eNp1kD1PwzAURS0EoqXwA1iQJWaDPxN7ROWjiEp0ADFaTuyUVK1T7GTIv8dRCkws9pPeufdJB4BLgm8IxvltJESxDGEiEOaEof4ITIlgHDEi1XGasaJI8oxPwFmMG4ypYFKeggnNOGaUkyl4mTe-DaZ0-7ZuPDTewlVwa2982cPV1nhf-zWsPfxodi69dfsJU2TtfN2aLVw4E1p4X0dnojsHJ5XZRndx-Gfg_fHhbb5Ay9en5_ndEpVU5j2yxhalKLnimTCMcSa4slblacAyVxlhzNlKFAWWUtFEVBkpTOGYFaUbsBm4Hnv3ofnqXGz1pumCTyc1VURxyXM6UGSkytDEGFyl96HemdBrgvWgT4_6dNKnB326T5mrQ3NX7Jz9Tfz4SgAdgZhWyUL4O_1_6zcFUnoz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2919484724</pqid></control><display><type>article</type><title>Contraception and Pregnancy Planning in Women With Congenital Heart Disease</title><source>ProQuest Central (Alumni Edition)</source><source>ProQuest Central UK/Ireland</source><source>SpringerLink Journals - AutoHoldings</source><source>ProQuest Central</source><creator>Lindley, Kathryn J. ; Conner, Shayna N. ; Cahill, Alison G. ; Madden, Tessa</creator><creatorcontrib>Lindley, Kathryn J. ; Conner, Shayna N. ; Cahill, Alison G. ; Madden, Tessa</creatorcontrib><description>Opinion statement
The cardiovascular risk of pregnancy among women with congenital heart disease is heterogeneous, ranging from negligible to prohibitively high. Nonetheless, many of these patients do not report being counseled about the potential risks, and the incidence of unintended pregnancy is high. These women should be counseled on safe and effective contraceptive options. Long-acting reversible contraceptives, including the intrauterine devices and etonogestrel implant, are highly effective and safe for all cardiac patients. These are good options for pregnancy planning for women at elevated risk of cardiovascular complications during pregnancy, who are taking potentially teratogenic medications, or who have contraindications to estrogen-containing methods. Pregnancy management begins with pre-conceptual risk stratification and counseling regarding individual cardiovascular and fetal risks. As significant lapse in care is common at the time of transition to adult congenital cardiology care, these discussions ideally begin in pediatric clinics and continue upon transfer of care to adult congenital cardiology clinics.</description><identifier>ISSN: 1092-8464</identifier><identifier>EISSN: 1534-3189</identifier><identifier>DOI: 10.1007/s11936-015-0413-y</identifier><identifier>PMID: 26403241</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Anticoagulants ; Birth control ; Cardiac arrhythmia ; Cardiology ; Cardiovascular disease ; Congenital diseases ; Contraindications ; Counseling ; Heart failure ; Maternal mortality ; Medicine ; Medicine & Public Health ; Methods ; Morbidity ; Obstetrics ; Patients ; Pediatric Congenital Heart Disease (G Singh ; Pediatrics ; Pregnancy ; Premature birth ; Risk factors ; Section Editor ; Topical Collection on Pediatric Congenital Heart Disease ; Womens health</subject><ispartof>Current treatment options in cardiovascular medicine, 2015-11, Vol.17 (11), p.50, Article 50</ispartof><rights>Springer Science+Business Media New York 2015</rights><rights>Springer Science+Business Media New York 2015.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c287y-dadbc5c49465a3343549dd9743508796133edf5bb08892a33f61babe3d5ce9743</citedby><cites>FETCH-LOGICAL-c287y-dadbc5c49465a3343549dd9743508796133edf5bb08892a33f61babe3d5ce9743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11936-015-0413-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2919484724?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,21388,21389,27924,27925,33530,33744,41488,42557,43659,43805,51319,64385,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26403241$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lindley, Kathryn J.</creatorcontrib><creatorcontrib>Conner, Shayna N.</creatorcontrib><creatorcontrib>Cahill, Alison G.</creatorcontrib><creatorcontrib>Madden, Tessa</creatorcontrib><title>Contraception and Pregnancy Planning in Women With Congenital Heart Disease</title><title>Current treatment options in cardiovascular medicine</title><addtitle>Curr Treat Options Cardio Med</addtitle><addtitle>Curr Treat Options Cardiovasc Med</addtitle><description>Opinion statement
The cardiovascular risk of pregnancy among women with congenital heart disease is heterogeneous, ranging from negligible to prohibitively high. Nonetheless, many of these patients do not report being counseled about the potential risks, and the incidence of unintended pregnancy is high. These women should be counseled on safe and effective contraceptive options. Long-acting reversible contraceptives, including the intrauterine devices and etonogestrel implant, are highly effective and safe for all cardiac patients. These are good options for pregnancy planning for women at elevated risk of cardiovascular complications during pregnancy, who are taking potentially teratogenic medications, or who have contraindications to estrogen-containing methods. Pregnancy management begins with pre-conceptual risk stratification and counseling regarding individual cardiovascular and fetal risks. As significant lapse in care is common at the time of transition to adult congenital cardiology care, these discussions ideally begin in pediatric clinics and continue upon transfer of care to adult congenital cardiology clinics.</description><subject>Anticoagulants</subject><subject>Birth control</subject><subject>Cardiac arrhythmia</subject><subject>Cardiology</subject><subject>Cardiovascular disease</subject><subject>Congenital diseases</subject><subject>Contraindications</subject><subject>Counseling</subject><subject>Heart failure</subject><subject>Maternal mortality</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Methods</subject><subject>Morbidity</subject><subject>Obstetrics</subject><subject>Patients</subject><subject>Pediatric Congenital Heart Disease (G Singh</subject><subject>Pediatrics</subject><subject>Pregnancy</subject><subject>Premature birth</subject><subject>Risk factors</subject><subject>Section Editor</subject><subject>Topical Collection on Pediatric Congenital Heart Disease</subject><subject>Womens health</subject><issn>1092-8464</issn><issn>1534-3189</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kD1PwzAURS0EoqXwA1iQJWaDPxN7ROWjiEp0ADFaTuyUVK1T7GTIv8dRCkws9pPeufdJB4BLgm8IxvltJESxDGEiEOaEof4ITIlgHDEi1XGasaJI8oxPwFmMG4ypYFKeggnNOGaUkyl4mTe-DaZ0-7ZuPDTewlVwa2982cPV1nhf-zWsPfxodi69dfsJU2TtfN2aLVw4E1p4X0dnojsHJ5XZRndx-Gfg_fHhbb5Ay9en5_ndEpVU5j2yxhalKLnimTCMcSa4slblacAyVxlhzNlKFAWWUtFEVBkpTOGYFaUbsBm4Hnv3ofnqXGz1pumCTyc1VURxyXM6UGSkytDEGFyl96HemdBrgvWgT4_6dNKnB326T5mrQ3NX7Jz9Tfz4SgAdgZhWyUL4O_1_6zcFUnoz</recordid><startdate>201511</startdate><enddate>201511</enddate><creator>Lindley, Kathryn J.</creator><creator>Conner, Shayna N.</creator><creator>Cahill, Alison G.</creator><creator>Madden, Tessa</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>201511</creationdate><title>Contraception and Pregnancy Planning in Women With Congenital Heart Disease</title><author>Lindley, Kathryn J. ; Conner, Shayna N. ; Cahill, Alison G. ; Madden, Tessa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c287y-dadbc5c49465a3343549dd9743508796133edf5bb08892a33f61babe3d5ce9743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Anticoagulants</topic><topic>Birth control</topic><topic>Cardiac arrhythmia</topic><topic>Cardiology</topic><topic>Cardiovascular disease</topic><topic>Congenital diseases</topic><topic>Contraindications</topic><topic>Counseling</topic><topic>Heart failure</topic><topic>Maternal mortality</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Methods</topic><topic>Morbidity</topic><topic>Obstetrics</topic><topic>Patients</topic><topic>Pediatric Congenital Heart Disease (G Singh</topic><topic>Pediatrics</topic><topic>Pregnancy</topic><topic>Premature birth</topic><topic>Risk factors</topic><topic>Section Editor</topic><topic>Topical Collection on Pediatric Congenital Heart Disease</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lindley, Kathryn J.</creatorcontrib><creatorcontrib>Conner, Shayna N.</creatorcontrib><creatorcontrib>Cahill, Alison G.</creatorcontrib><creatorcontrib>Madden, Tessa</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Current treatment options in cardiovascular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lindley, Kathryn J.</au><au>Conner, Shayna N.</au><au>Cahill, Alison G.</au><au>Madden, Tessa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Contraception and Pregnancy Planning in Women With Congenital Heart Disease</atitle><jtitle>Current treatment options in cardiovascular medicine</jtitle><stitle>Curr Treat Options Cardio Med</stitle><addtitle>Curr Treat Options Cardiovasc Med</addtitle><date>2015-11</date><risdate>2015</risdate><volume>17</volume><issue>11</issue><spage>50</spage><pages>50-</pages><artnum>50</artnum><issn>1092-8464</issn><eissn>1534-3189</eissn><abstract>Opinion statement
The cardiovascular risk of pregnancy among women with congenital heart disease is heterogeneous, ranging from negligible to prohibitively high. Nonetheless, many of these patients do not report being counseled about the potential risks, and the incidence of unintended pregnancy is high. These women should be counseled on safe and effective contraceptive options. Long-acting reversible contraceptives, including the intrauterine devices and etonogestrel implant, are highly effective and safe for all cardiac patients. These are good options for pregnancy planning for women at elevated risk of cardiovascular complications during pregnancy, who are taking potentially teratogenic medications, or who have contraindications to estrogen-containing methods. Pregnancy management begins with pre-conceptual risk stratification and counseling regarding individual cardiovascular and fetal risks. As significant lapse in care is common at the time of transition to adult congenital cardiology care, these discussions ideally begin in pediatric clinics and continue upon transfer of care to adult congenital cardiology clinics.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>26403241</pmid><doi>10.1007/s11936-015-0413-y</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1092-8464 |
| ispartof | Current treatment options in cardiovascular medicine, 2015-11, Vol.17 (11), p.50, Article 50 |
| issn | 1092-8464 1534-3189 |
| language | eng |
| recordid | cdi_proquest_journals_2919484724 |
| source | ProQuest Central (Alumni Edition); ProQuest Central UK/Ireland; SpringerLink Journals - AutoHoldings; ProQuest Central |
| subjects | Anticoagulants Birth control Cardiac arrhythmia Cardiology Cardiovascular disease Congenital diseases Contraindications Counseling Heart failure Maternal mortality Medicine Medicine & Public Health Methods Morbidity Obstetrics Patients Pediatric Congenital Heart Disease (G Singh Pediatrics Pregnancy Premature birth Risk factors Section Editor Topical Collection on Pediatric Congenital Heart Disease Womens health |
| title | Contraception and Pregnancy Planning in Women With Congenital Heart Disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T21%3A37%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Contraception%20and%20Pregnancy%20Planning%20in%20Women%20With%20Congenital%20Heart%20Disease&rft.jtitle=Current%20treatment%20options%20in%20cardiovascular%20medicine&rft.au=Lindley,%20Kathryn%20J.&rft.date=2015-11&rft.volume=17&rft.issue=11&rft.spage=50&rft.pages=50-&rft.artnum=50&rft.issn=1092-8464&rft.eissn=1534-3189&rft_id=info:doi/10.1007/s11936-015-0413-y&rft_dat=%3Cproquest_cross%3E2919484724%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2919484724&rft_id=info:pmid/26403241&rfr_iscdi=true |